cilostazol has been researched along with Hypertrophy, Left Ventricular in 1 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, R | 1 |
| Powell-Braxton, L | 1 |
| Ogaoawara, AK | 1 |
| Dybdal, N | 1 |
| Bunting, S | 1 |
| Ohneda, O | 1 |
| Jin, H | 1 |
1 other study available for cilostazol and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Hypertension and endothelial dysfunction in apolipoprotein E knockout mice.
Topics: Age Factors; Animals; Apolipoproteins E; Arteriosclerosis; Cholesterol; Cilostazol; Endothelium, Vas | 1999 |